Insider for issuer (GWRE) files Form 144 to sell 1,200 shares
Rhea-AI Filing Summary
A holder of GWRE common stock filed a Form 144 to sell 1,200 shares of common stock through Morgan Stanley Smith Barney LLC on or about 01/20/2026 on the NYSE. The planned sale relates to performance shares acquired from the issuer on 09/15/2022. The filing notes that 85,019,176 common shares were outstanding at the time, which provides a baseline for the issuer’s overall equity. Over the prior three months, the same seller, Mike Rosenbaum, reported multiple open-market sales of common stock, including 6,015 shares on 10/16/2025 for gross proceeds of $1,155,337.74 and 1,200 shares on 01/13/2026 for $217,044.00. The signer represents that they are not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
FAQ
What does this Form 144 filing for GWRE indicate?
This Form 144 shows that a holder of GWRE common stock intends to sell 1,200 shares through Morgan Stanley Smith Barney LLC, with an approximate sale date of 01/20/2026 on the NYSE.
Who is selling GWRE shares and how many are involved in the new notice?
The seller is Mike Rosenbaum, who filed to sell 1,200 shares of GWRE common stock under this Form 144 notice.
How were the GWRE shares in this Form 144 originally acquired?
The 1,200 GWRE common shares covered by this notice were acquired on 09/15/2022 as performance shares from the issuer, with the nature of payment listed as Not Applicable.
What GWRE share sales has the seller made in the past three months?
Over the past three months, Mike Rosenbaum reported several sales of GWRE common stock, including 6,015 shares on 10/16/2025 for
How many GWRE shares were outstanding when this Form 144 was prepared?
The Form 144 states that 85,019,176 shares of GWRE common stock were outstanding, providing a baseline figure for the issuer’s equity.
What representation does the seller make about information on GWRE?
By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.